跳至主要内容
临床试验/ACTRN12605000495628
ACTRN12605000495628已完成未知

The Relationship of single nucleotide polymorphisms in the Interleukin-7 receptor-gene to CD4+ immune recovery in HIV infected patients who begin antiretroviral treatment with HAART

HMRC0 个研究点目标入组 110 人开始时间: 2005年9月23日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 ot stated(—)
性别
All

入选标准

  • First antiretroviral regimen composed of HAART as defined by at least three antiretrovirals. Controlled viremia for a period of at least 12 months following commencement of HAART. Controlled viremia is defined as HIV viral load of 500 copies/mL on bDNA testing (versions 2 and 3) and <400 copies/ml measured by RT-PCR assay by 6 months treatment. CD4 cell count <500 at commencement of HAART. Measurement of CD4+ cell count on at least 3 time points, in the 12 months post commencement of HAART.

排除标准

  • Exclude patients treated for HIV seroconversion illness. Exclude patients on immunomodulatory therapy such as IL-2, hydroxyurea or prednisolone or who have received an HIV therapeutic vaccine.

研究者

发起方
HMRC

相似试验

The Relationship of single nucleotide polymorphisms... | 临床试验